HSA approves molnupiravir
Singapore OKs molnupiravir for COVID-19 treatment
Singapore OKs molnupiravir for COVID-19 treatment
The drug is the second oral antiviral medicine authorised for COVID-19 treatment.
Most Read
1. Gleneagles HK to advance health solutions through new partnerships 2. Temasek-backed SeaTown invests $115m in AddVita 3. Here’s what’s next for Japan’s mycobacterium tuberculosis tests market 4. SingHealth, Philips to roll out smart ICUs to cut false alarms 5. The Medical City brings home five wins at Healthcare Asia Awards 2025Resource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
It was recognised for its success in delivering world-class specialised services that rival the best healthcare institutions globally.
Commentary
Strategic brand & design: A smart prescription to drive growth in healthcare